Search

everythinglearnresearchcommunity

for

Search:↓

New peptide biomaterials based on RADA16-I hydrogel can improve wound healing and could be used for tissue engineering.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

PRP injections improve knee function in osteoarthritis.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Tofacitinib may help treat hair loss in children with alopecia areata.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Leflunomide is more likely to help treat alopecia areata than cause it.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Monoclonal antibodies are often linked to alopecia areata cases.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

ASC-CM is more effective than EV for treating osteoarthritis.

Co-trimoxazole may help treat autoimmune diseases.

Dupilumab may help regrow hair in people with atopic dermatitis.

Indometacin was chosen for a gel to help treat mastopathy and prevent breast cancer.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Accidental injection of hyaluronic acid caused temporary hair loss and skin damage, but treatment restored hair and healed the skin.